Prestige Consumer Healthcare
PBH
#4293
Rank
A$3.65 B
Marketcap
A$75.97
Share price
-9.02%
Change (1 day)
-44.16%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): A$5.84

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.52. In 2024 the company made an earnings per share (EPS) of A$6.22 an increase over its 2023 EPS that were of A-$2.33.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$5.84-6.15%
2024A$6.22-367.08%
2023A-$2.33-138.33%
2022A$6.0811.7%
2021A$5.4413.6%
2020A$4.79-651.67%
2019A-$0.87-148.78%
2018A$1.78-83.29%
2017A$10.65437.23%
2016A$1.98-34.13%
2015A$3.0152.94%
2014A$1.97-8.11%
2013A$2.14
2011A$1.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$16.12 192.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$10.00 81.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.42 88.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.97-64.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.43-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.90 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$2.04-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.45-1.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$42.88-877.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.77-67.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel